In patients with EMs, cytokines(IL-1β, IL-6, and TNF-α), growth factors(NGF and VEGF) and chemokines are upregulated to participate in peripheral neural sensitization or amplify inflammatory responses in the microenvironment, resulting in dysmenorrhea [19, 20]. Here, IL1B is linked to eosinophilia-myalgia syndrome.